Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

RFA for Superficial Lipomas

NCT: NCT06903208 · RECRUITING

NCT IDNCT06903208
StatusRECRUITING
Start Date2025-04-02
Completion2027-07
SponsorColumbia University (OTHER)
First posted
Last updated

Brief Summary

Lipomas are non-cancerous growths of fatty tissue that develop under the skin in approximately 1 in 1000 people, though this number may be higher. While rarely symptomatic, they often cause emotional distress due to the unappealing appearance of the mass. Treatment of unsightly lipomas is excision with local anesthetic in the office or with sedation in the operating room. The recovery period is short and the procedure is low risk; however, the result of the operation is a visible scar over the site of the lipoma. Many patients defer surgical excision because excision of a lipoma is a cosmetic procedure, but the aesthetic outcome is undesirable. Radiofrequency ablation (RFA) is a technique that applies heat generated by a high frequency, alternating current to soft tissue. The hyperthermia produced by the current causes tissue necrosis that ablates the tissue into which the energy is directed. RFA has been successfully applied to thyroid nodules, pancreatic lesions, esophageal dysplasia and liver tumors. However, the manufacturers of the RFA technology have been focused on its application in pre-malignant and malignant lesions and have not yet considered its application to benign tumors. This study will test the success of RFA for superficial lipomas as a non-surgical option for treatment.

Frequently Asked Questions

What is RFA for Superficial Lipomas?

RFA for Superficial Lipomas is a clinical trial registered under NCT06903208. Current status: RECRUITING.

What is the status of NCT06903208?

The current status of NCT06903208 (RFA for Superficial Lipomas) is: RECRUITING.

When did RFA for Superficial Lipomas start?

RFA for Superficial Lipomas started on 2025-04-02.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.